Clinical Trials · NCT05263388
A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 302
- Start date
- Jul 2022
- Locations
- 16 sites, 5 countries
- Primary endpoint
- Number of Oocytes Retrieved